NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Abbott Laboratories (SW: ABT)

 
ABT Technical Analysis
4
As on 4th Apr 2023 ABT STOCK Price closed @ 91.50 and we RECOMMEND Sell for LONG-TERM with Stoploss of 91.62 & Strong Sell for SHORT-TERM with Stoploss of 104.36 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

ABTSTOCK Price

Open 91.50 Change Price %
High 91.50 1 Day -3.50 -3.68
Low 91.50 1 Week -14.50 -13.68
Close 91.50 1 Month -22.50 -19.74
Volume 1 1 Year -3.50 -3.68
52 Week High 128.00 | 52 Week Low 6.75
 
SW Switzerland Most Active Stocks
CSGN 0.81 %
CSGN 0.81 %
MBTN 0.58 %
ABBN 34.50 %
ABBN 34.50 %
UBSG 18.20 %
UBSG 18.20 %
NOVN 90.17 %
NOVN 90.17 %
NESN 107.16 %
 
SW Switzerland Top Gainers Stocks
PRFN 0.03 50.00%
PRFN 0.03 50.00%
BLS 0.13 18.18%
BLS 0.13 18.18%
BLS 0.13 18.18%
NEWN 0.94 17.50%
CASN 1.90 8.57%
SKIN 32.50 8.33%
SKIN 32.50 8.33%
GUR 1258.00 2.78%
 
SW Switzerland Top Losers Stocks
CON 98.00 -12.35%
CON 98.00 -12.35%
CON 98.00 -12.35%
CON 98.00 -12.35%
CON 98.00 -12.35%
CON 98.00 -12.35%
CON 98.00 -12.35%
CON 98.00 -12.35%
LINN 585.00 -7.87%
ABT 91.50 -3.68%
 
 
ABT
Daily Charts
ABT
Intraday Charts
Whats New @
Bazaartrend
ABT
Free Analysis
 
ABT Important Levels Intraday
RESISTANCE91.50
RESISTANCE91.50
RESISTANCE91.50
RESISTANCE91.50
RESISTANCE91.50
RESISTANCE91.50
RESISTANCE91.50
RESISTANCE91.50
 
ABT Forecast December 2023
4th UP Forecast122.33
3rd UP Forecast112.44
2nd UP Forecast106.33
1st UP Forecast100.22
1st DOWN Forecast82.78
2nd DOWN Forecast76.67
3rd DOWN Forecast70.56
4th DOWN Forecast60.67
 
ABT Weekly Forecast
4th UP Forecast102.10
3rd UP Forecast98.70
2nd UP Forecast96.60
1st UP Forecast94.50
1st DOWN Forecast88.50
2nd DOWN Forecast86.40
3rd DOWN Forecast84.30
4th DOWN Forecast80.90
 
ABT Forecast2023
4th UP Forecast338.16
3rd UP Forecast259.05
2nd UP Forecast210.16
1st UP Forecast161.26
1st DOWN Forecast21.74
2nd DOWN Forecast-27.16
3rd DOWN Forecast-76.05
4th DOWN Forecast-155.16
 
 
ABT Other Details
Segment EQ
Market Capital 207061041152.00
Sector Healthcare
Industry Medical Devices
Offical website >
 
ABT Address
ABT
 
ABT Latest News
 
Your Comments and Response on Abbott Laboratories
 
ABT Business Profile
Abbott Laboratories discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. The Diagnostic Products segment offers laboratory systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, as well as detect and measure infectious agents; point of care systems; cartridges for testing blood; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for use in laboratories. The Nutritional Products segment provides pediatric and adult nutritional products. The Medical Devices segment offers rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; and diabetes care products, as well as neuromodulation devices for the management of chronic pain and movement disorders. It has collaboration agreement with Cereno Scientific AB (publ). The company was founded in 1888 and is based in North Chicago, Illinois. Address: 100 Abbott Park Road, North Chicago, IL, United States, 60064-6400
 
2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service